Stock Events

Alnylam Pharmaceuticals (ALNY) Q3 2021 Earnings

3AugConfirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
-2.18
-1.99
-1.8
-1.61

Details

Expected EPS
-1.65
Actual EPS
-1.61
Surprise EPS
0.04
Surprise Percent
+2.42%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.61 per share for Q3 2021.

0 Comments

Share your thoughts